PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiovascular Medicine, Department of Medicine, UC San Diego, La Jolla, California, United States of America.\', \'Division of Epidemiology, Department of Family Medicine and Public Health, UC San Diego, La Jolla, California, United States of America.\', \'Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, UC San Diego, La Jolla, California, United States of America.\', \'Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, United States of America.\', \'UCSD Moores Cancer Center, UC San Diego, La Jolla, California, United States of America.\', \'Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.\', \'Pennsylvania State Health, Hershey, Pennsylvania, United States of America.\', \'Department of Medicine, UC San Diego, La Jolla, California, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0254635
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34264974
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association\'s COVID-19 Cardiovascular Disease Registry.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all